Walpar Nutritions Ltd
Incorporated in 2009, Walpar Nutritions Ltd manufactures and trades Pharmaceutical, Nutraceutical, Herbal and Ayurvedic commodities[1]
- Market Cap ₹ 44.3 Cr.
- Current Price ₹ 47.2
- High / Low ₹ 77.0 / 39.0
- Stock P/E 17.9
- Book Value ₹ 16.6
- Dividend Yield 0.00 %
- ROCE 12.8 %
- ROE 11.9 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 111 to 78.5 days.
- Company's working capital requirements have reduced from 113 days to 68.2 days
Cons
- Stock is trading at 2.85 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -2.79%
- Company has a low return on equity of 7.79% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|
| 6.07 | 26.76 | 35.14 | 62.52 | 63.91 | |
| 5.61 | 25.74 | 31.65 | 57.77 | 58.51 | |
| Operating Profit | 0.46 | 1.02 | 3.49 | 4.75 | 5.40 |
| OPM % | 7.58% | 3.81% | 9.93% | 7.60% | 8.45% |
| 0.00 | 0.02 | 0.32 | 0.22 | 0.47 | |
| Interest | 0.18 | 0.48 | 0.79 | 0.67 | 0.60 |
| Depreciation | 0.12 | 0.28 | 1.91 | 1.81 | 1.77 |
| Profit before tax | 0.16 | 0.28 | 1.11 | 2.49 | 3.50 |
| Tax % | 6.25% | -32.14% | 27.03% | 22.09% | |
| 0.15 | 0.36 | 0.81 | 1.94 | 2.70 | |
| EPS in Rs | 0.22 | 0.42 | 0.65 | 1.68 | 2.63 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 118% |
| TTM: | 28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 117% |
| TTM: | 79% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 43% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 8% |
| Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|
| Equity Capital | 3.34 | 4.54 | 4.54 | 4.70 | 9.39 |
| Reserves | 1.44 | 6.45 | 7.17 | 9.49 | 6.16 |
| 7.49 | 7.25 | 10.30 | 8.30 | 8.56 | |
| 5.73 | 9.85 | 12.29 | 14.67 | 21.79 | |
| Total Liabilities | 18.00 | 28.09 | 34.30 | 37.16 | 45.90 |
| 1.70 | 2.01 | 10.13 | 10.20 | 10.32 | |
| CWIP | 1.22 | 4.48 | 0.02 | 0.02 | 0.02 |
| Investments | 0.00 | 0.49 | 0.02 | 1.88 | 1.88 |
| 15.08 | 21.11 | 24.13 | 25.06 | 33.68 | |
| Total Assets | 18.00 | 28.09 | 34.30 | 37.16 | 45.90 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| -0.31 | -1.08 | 1.10 | 5.35 | |
| -2.02 | -6.14 | -3.44 | -3.61 | |
| 2.95 | 6.71 | 2.42 | -1.77 | |
| Net Cash Flow | 0.62 | -0.51 | 0.07 | -0.03 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Debtor Days | 430.54 | 124.26 | 129.63 | 78.46 |
| Inventory Days | 369.26 | 103.22 | 128.73 | 67.15 |
| Days Payable | 455.40 | 135.07 | 143.88 | 72.94 |
| Cash Conversion Cycle | 344.41 | 92.41 | 114.48 | 72.67 |
| Working Capital Days | 487.07 | 138.17 | 131.40 | 68.19 |
| ROCE % | 4.85% | 8.78% | 12.75% |
Documents
Announcements
-
Outcome of Board Meeting
12 November 2024 - Outcome of Board Meeting held today i.e. 12th November, 2024
-
Financial Result Updates
12 November 2024 - Walpar Nutritions Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024.
-
Board Meeting Intimation
7 November 2024 - WALPAR NUTRITIONS LIMITED has informed about Board Meeting to be held on 12-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company …
-
Updates
11 October 2024 - Walpar Nutritions Limited has informed regarding 'Submission of Certificate under Regulation 74(5) of SEBI (Depository and Participant) Regulation, 2018 for the Quarter ended on 30th …
-
Updates
11 October 2024 - Walpar Nutritions Limited has informed regarding 'Non-applicability of Corporate Governance Provisions as per SEBI (LODR) Regulation, 2015'.
Business Overview:[1]
Company manufactures and sells Nutraceutical and Herbal dietary supplement formulations, ingredients and research. It manufactures private label brands for different companies and its own brands, selling through online and direct channels. Company is a specialized Contract manufacturer for different formulation in Nutraceuticals and Herbal products